Eric Richards

About Eric Richards

Successfully led substantial organizational changes in challenging environments. Innovative, passionate, and open leadership style that has proven to inspire people to lead within and outside my function, and to follow me to several different companiesBroad global drug development experience from early to late stage to post-marketing, as a function head to individual contributor involving novel/novel combinations, CDx, IO, ADC and globally simultaneous submissions Six different new drugs approved in at least one major market (MEKINIST, TAFINLAR, TAGRISSO, TURALIO, VANFLYTA, ENHERTU) with numerous additional indications for OPDIVO and YERVOY. The fast ever drug development in oncology (TAGRISSO, FIH to approval 2 years, 8 months) and 2nd fastest biologics (ENHERTU)

Experience

1. Senior Vice President, Head of Medicine Development Leaders (Oncology)

   GSK

   Apr 2024 — Present · Upper Providence, PA, US

   Leading a department of individuals who act the single point of accountability for medicines in the clinical stage oncology portfolio

Education

• Walden

  MPH

  2008 — 2010

• Temple University

  MS, QA/RA

  2000 — 2002

• The New School

  BFA, Musical Theatre

  1998 — 2000

• Harvard Business School

  PLD, Business Administration and Management, General

• Harvard Medical School

  Certificate, Executive Program for Senior Life Science Leaders

Skills

• Therapeutic Areas
• Regulatory Affairs
• U.s. Food and Drug Administration (Fda)
• Regulatory Requirements
• Ind
• Clinical Research
• Pharmaceutical Industry
• Sop
• Fda
• Strategy
• Neurology
• Clinical Trials
• Oncology
• Drug Development
• Standard Operating Procedure (Sop)
• Clinical Development
• Biotechnology
• Cmc
• Regulatory Submissions